Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Jun 2026 for IDT CORP. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
William Conkling: trading record in brief
This profile gathers the share dealings of William Conkling across 4 companies, led by Rafael Holdings, Inc., Cyclo Therapeutics, Inc. and Protara Therapeutics, Inc. In total, 26 filings cover trades dated from 1 February 2022 to 9 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 11 June 2026: a share grant, in IDT Corp. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Conkling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
673 sharesClass B Common Stock, $.01 par value per shareSEC:0001193125-26-267388:0
6,008 shares@ US$4.340.011% mcap100.0% of flowCommon StockSEC:0001213900-26-064792:0
26,000 shares0Common StockSEC:0001213900-26-006231:0
50,000 shares0Common StockSEC:0001213900-25-051157:0
27,454 sharesClass B Common Stock, par value $.01 per shareSEC:0000950170-25-057934:0
14,814 shares@ US$1.935.4% of flowClass B Common Stock, par value $.01 per shareSEC:0000950170-25-044469:0
27,654 shares0Common StockSEC:0001437749-25-005852:0
60,000 shares@ US$1.95423.5% of flowClass B Common Stock, par value $.01 per shareSEC:0000950170-25-005759:0
12,807 shares@ US$1.8354.7% of flowClass B Common Stock, par value $.01 per shareSEC:0000950170-24-139519:0
16,660 shares0Common StockSEC:0001437749-24-035589:0
3,431 shares@ US$1.841.2% of flowClass B Common Stock, par value $.01 per shareSEC:0000950170-24-118362:0
12,696 shares@ US$1.7254.0% of flowClass B Common Stock, par value $.01 per shareSEC:0000950170-24-108970:0
8,731 shares0Common StockSEC:0001437749-24-027331:0
13,295 shares@ US$1.4553.7% of flowClass B Common Stock, par value $.01 per shareSEC:0000950170-24-077206:0
8,594 shares0Common StockSEC:0001437749-24-019341:0
15,473 shares@ US$1.7055.0% of flowClass B Common Stock, par value $.01 per shareSEC:0000950170-24-035671:0
6,330 shares0Common StockSEC:0001437749-24-004379:0
13,602 shares@ US$1.824.7% of flowClass B Common Stock, par value $.01 per shareSEC:0001209191-23-059658:0
7,466 shares0Common StockSEC:0001437749-23-033221:0
40,000 shares@ US$1.51511.8% of flowClass B Common Stock, par value $.01 per shareSEC:0001209191-23-053663:0
13,669 shares@ US$2.20512.2% of flowClass B Common Stock, par value $.01 per shareSEC:0001209191-23-050342:0
2,449 shares0Common StockSEC:0001437749-23-024418:0
15,170 shares@ US$2.156.1% of flowClass B Common Stock, par value $.01 per shareSEC:0001209191-23-039011:0
15,625 shares@ US$1.675.0% of flowClass B Common Stock, par value $.01 per shareSEC:0001209191-23-020694:0
56,149 shares@ US$1.7619.1% of flowClass B Common Stock, par value $.01 per shareSEC:0001209191-22-062549:0
25 of 26 declarations
